Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Claritin efficacy and advertising in healthy subjects
NCT01451996Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Oct 2011
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of loratadine in allergic rhinitis (AR), urticaria, sponsored by University of Chicago. Started Oct 2011; status: completed.
02
Drugs
loratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on NCT01451996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451996.